Using voice technology to improve post-surgery care for gastrointestinal cancer patients
REmote Symptom COllection to improVE postopeRative Care
This study is testing whether a voice technology system can help improve the recovery and care of patients after surgery for gastrointestinal cancer compared to standard care.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 281 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Medstar Health Research Institute Academic / other |
| Locations | 2 sites (Baltimore, Maryland and 1 other locations) |
| Trial ID | NCT06190730 on ClinicalTrials.gov |
What this trial studies
This study investigates the effectiveness of a Voice-Assisted Remote Symptom Monitoring System (VARSMS) to enhance post-operative care for patients who have undergone surgery for malignant gastrointestinal tumors. It is a randomized controlled trial where participants will be assigned to either use the VARSMS or receive standard care. The goal is to address vulnerabilities in the transition of care after discharge by providing a technological solution for symptom monitoring. The study will assess the impact of this intervention on patient outcomes and satisfaction.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 and older who are scheduled for gastrointestinal surgery and can communicate in English.
Not a fit: Patients who are unable to provide informed consent or have a life expectancy of less than 60 days may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly improve the quality of post-operative care and patient outcomes for those recovering from gastrointestinal cancer surgery.
How similar studies have performed: Other studies utilizing remote monitoring technologies have shown promise in improving patient outcomes, suggesting that this approach may be effective.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion criteria 1. At least 18 years old. Ages of subjects \>89 will simply be reported as \>90. 2. Scheduled for a GI surgery for management of a tumor in a participating hospital. 3. Fluent in oral and written English. 4. Has consistent and continued full access to an operational Wi-Fi for the duration of the study. Exclusion criteria 1. Unable to provide informed consent. 2. Not willing to commit to regular participation in the study to include daily use (40 days) of the study application. 3. Life expectancy of less than 60 days. 4. In the opinion of the investigator, participation in this study is contraindicated.
Where this trial is running
Baltimore, Maryland and 1 other locations
- MedStar Health — Baltimore, Maryland, United States (Recruiting)
- Creighton University — Omaha, Nebraska, United States (Recruiting)
Study contacts
- Study coordinator: Nawar Shara, PhD
- Email: nawar.shara@medstar.net
- Phone: 301-502-0339
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.